Assessment of recent process analytical technology (PAT) trends: a multiauthor review LL Simon, H Pataki, G Marosi, F Meemken, K Hungerbühler, A Baiker, ... Organic Process Research & Development 19 (1), 3-62, 2015 | 446 | 2015 |
Applications of process analytical technology to crystallization processes XY Lawrence, RA Lionberger, AS Raw, R D'Costa, H Wu, AS Hussain Advanced drug delivery reviews 56 (3), 349-369, 2004 | 421 | 2004 |
Quality-by-Design (QbD): An integrated process analytical technology (PAT) approach for a dynamic pharmaceutical co-precipitation process characterization and process design … H Wu, M White, MA Khan International journal of pharmaceutics 405 (1-2), 63-78, 2011 | 153 | 2011 |
Quality-by-Design (QbD): An integrated multivariate approach for the component quantification in powder blends H Wu, M Tawakkul, M White, MA Khan International Journal of Pharmaceutics 372 (1-2), 39-48, 2009 | 116 | 2009 |
Real-time on-line blend uniformity monitoring using near-infrared reflectance spectrometry: a noninvasive off-line calibration approach Y Sulub, B Wabuyele, P Gargiulo, J Pazdan, J Cheney, J Berry, A Gupta, ... Journal of pharmaceutical and biomedical analysis 49 (1), 48-54, 2009 | 98 | 2009 |
Process analytical technology (PAT): Quantification approaches in terahertz spectroscopy for pharmaceutical application H Wu, EJ Heilweil, AS Hussain, MA Khan Journal of pharmaceutical sciences 97 (2), 970-984, 2008 | 81 | 2008 |
Quality-by-design (QbD): an integrated approach for evaluation of powder blending process kinetics and determination of powder blending end-point H Wu, MA Khan Journal of pharmaceutical sciences 98 (8), 2784-2798, 2009 | 80 | 2009 |
A quantitative study of the effect of process parameters on key granule characteristics in a high shear wet granulation process involving a two component pharmaceutical blend S Oka, O Kašpar, V Tokárová, K Sowrirajan, H Wu, M Khan, F Muzzio, ... Advanced Powder Technology 26 (1), 315-322, 2015 | 69 | 2015 |
Process analytical technology (PAT): Effects of instrumental and compositional variables on terahertz spectral data quality to characterize pharmaceutical materials and tablets H Wu, EJ Heilweil, AS Hussain, MA Khan International Journal of Pharmaceutics 343 (1-2), 148-158, 2007 | 68 | 2007 |
Positron annihilation spectroscopy study of interfacial defects formed by dissolution of aluminum in aqueous sodium hydroxide KR Hebert, H Wu, T Gessmann, K Lynn Journal of the Electrochemical Society 148 (2), B92, 2001 | 68 | 2001 |
Process control perspective for process analytical technology: integration of chemical engineering practice into semiconductor and pharmaceutical industries H Wu, MA Khan, AS Hussain Chemical Engineering Communications 194 (6), 760-779, 2007 | 63 | 2007 |
Robust calibration design in the pharmaceutical quantitative measurements with near‐infrared (NIR) spectroscopy: Avoiding the chemometric pitfalls D Xiang, J Berry, S Buntz, P Gargiulo, J Cheney, Y Joshi, B Wabuyele, ... Journal of pharmaceutical sciences 98 (3), 1155-1166, 2009 | 60 | 2009 |
Quality-by-design (QbD): effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation … LIN Xie, H Wu, M Shen, LL Augsburger, RC Lyon, MA Khan, AS Hussain, ... Journal of pharmaceutical sciences 97 (10), 4485-4497, 2008 | 60 | 2008 |
Risk considerations on developing a continuous crystallization system for carbamazepine X Yang, D Acevedo, A Mohammad, N Pavurala, H Wu, AL Brayton, ... Organic Process Research & Development 21 (7), 1021-1033, 2017 | 58 | 2017 |
A mechanistic population balance model for granulation processes: effect of process and formulation parameters A Chaudhury, H Wu, M Khan, R Ramachandran Chemical Engineering Science 107, 76-92, 2014 | 56 | 2014 |
Assessment of NIR spectroscopy for nondestructive analysis of physical and chemical attributes of sulfamethazine bolus dosage forms AS Tatavarti, R Fahmy, H Wu, AS Hussain, W Marnane, D Bensley, ... aaps Pharmscitech 6, E91-E99, 2005 | 56 | 2005 |
Quality‐by‐Design (QbD): An integrated process analytical technology (PAT) approach for real‐time monitoring and mapping the state of a pharmaceutical coprecipitation process H Wu, MA Khan Journal of pharmaceutical sciences 99 (3), 1516-1534, 2010 | 54 | 2010 |
Population balance model development, validation, and prediction of CQAs of a high-shear wet granulation process: towards QbD in drug product pharmaceutical manufacturing A Chaudhury, D Barrasso, P Pandey, H Wu, R Ramachandran Journal of Pharmaceutical Innovation 9, 53-64, 2014 | 48 | 2014 |
An integrated process analytical technology (PAT) approach for pharmaceutical crystallization process understanding to ensure product quality and safety: FDA scientist’s … H Wu, Z Dong, H Li, M Khan Organic Process Research & Development 19 (1), 89-101, 2015 | 47 | 2015 |
THz spectroscopy: An emerging technology for pharmaceutical development and pharmaceutical Process Analytical Technology (PAT) applications H Wu, M Khan Journal of Molecular Structure 1020, 112-120, 2012 | 44 | 2012 |